Abstract
The diverse host defense and immunoregulatory functions of human T cells are performed by phenotypically heterogeneous subpopulations. Among the membrane antigens that are differentially expressed by reciprocal human T-cell subsets are the CD45RA and CD45RO isoforms of the common leukocyte antigen family, which have been hypothesized to identify “naive” and “memory” T cells, respectively. The CD45RA antigen is first expressed by T-lineage cells relatively late during their intrathymic maturation and continues to be expressed by most T cells in the immunologically naive neonate. With increasing age and antigenic exposure, however, CD45RA-/RO+ cells become more prevalent in the circulation and comprise the majority of cells in tissues. Analyses of the functional capabilities of CD4+CD45RA+ and CD4+CD45RO+ cells have shown that proliferative responses to “memory” recall antigens or the ability to provide help for antibody production are functions uniquely performed by CD4+CD45RA-/RO+ cells. The major immunoregulatory functions described for CD4+CD45RA+ cells involve suppression of immune responses, either directly or via the induction of suppressor activity by CD8+ cells. Two general models of differentiation have been proposed to describe the lineal relationship of these T-cell subsets. Although these subsets could represent mature, phenotypically and functionally stable progeny arising from separate differentiation pathways, there is considerable experimental support for the hypothesis that CD45RA-/RO+ cells are “memory” cells that derive from “naive” or “virgin” CD45RA+/RO-precursors via an activation-dependent postthymic differentiation pathway. Altered frequencies of CD45RA+ and CD45RO+ T cells have been observed in a variety of different clinical conditions, particularly diseases manifesting altered immune function. These findings have contributed new information concerning the physiological events regulating thein vivo generation of these T-cell subsets. In addition, they may provide clues to the pathogenetic processes associated with certain diseases.
Similar content being viewed by others
References
Pulido R, Sanchez-Madrid F: Biochemical nature and topographic localization of epitopes defining four distinct CD45 antigen specificities. Conventional CD45, CD45R, 180 kDa (UCHL1) and 220/205/190 kDa. J Immunol 143:1930–1936, 1989
Streuli M, Hall LR, Saga Y, Schlossman SF, Saito H: Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J Exp Med 166:1548–1566, 1987
Tedder TF, Clement LT, Cooper MD: Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression. J Immunol 134:2983–2988, 1985
Smith SH, Brown MH, Rowe D, Callard RE, Beverley PCL: Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology 58:63–70, 1986
Pingel, JT, Thomas ML: Evidence that the leukocytecommon antigen is required for antigen-induced T lymphocyte proliferation. Cell 58:1055–1065, 1989
Schraven B, Roux M, Hutmacher B, Meuer SC: Triggering of the alternative pathway of human T cell activation involves members of the T200 family of glycoproteins. Eur J Immunol 19:397–403, 1989
Martorell J, Vilella R, Borche L, Rojo I, Vives J: A second signal for T cell mitogenesis provided by monoclonal antibodies CD45 (T200). Eur J Immunol 17:1447–1451, 1987
Ledbetter JA, Rose LM, Spooner CE, Beatty PG, Martin PJ, Clark EA: Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL-2 receptor expression. J Immunol 135:1819–1828, 1985
Tonks NK, Charbonneau H, Diltz CD, Fischer EH, Walsh KA: Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase. Biochemistry 27:8695–8704, 1988
Schraven B, Samstag Y, Altevogt P, Meuer S: Association of CD2 and CD45 on human T lymphocytes. Nature 345:71–74, 1990
Volarevic S, Burns CM, Sussman JJ, Ashwell JD: Intimate association of Thy-1 and the T-cell antigen receptor with the CD45 tyrosine phosphatase. Proc Natl Acad Sci USA 87:7085–7092, 1990
Kiener PA, Mittler RS: CD45-protein tyrosine phosphatase cross-linking inhibits T cell receptor CD3-mediated activation in human T cells. J Immunol 143:23–30, 1989
Ledbetter JA, Tonks NK, Fisher EH, Clark EA: CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells. Proc Natl Acad Sci USA 85:8628–8634, 1988
Mustelin T, Coggeshall KM, Altman A: Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phophotyrosine phosphatase. Proc Natl Acad Sci USA 86:6302–6308, 1989
Janossy G, Bofill M, Rowe D, Muir J, Beverley PCL: The tissue distribution of T lymphocytes expressing different CD45 polypeptides. Immunology 66:517–525, 1989
Gillitzer R, Pilarski LM: In situ localization of CD45 isoforms in the human thymus indicates a medullary location for the thymic generative lineage. J Immunol 144:66–74, 1990
Pilarski LM, Deans JP: Selective expression of CD45 isoforms and of maturation antigens during human thymocyte differentiation: Observations and hypothesis. Immunol Lett 21:187–198, 1989
Uittenbogaart C, Higashitani S, Scmid I, Boone T, Clement LT: Interleukin-4 induces expression of the CD45RA antigen on human thymocyte subpopulations. Intl Immunol 2:1179–1187, 1990
Merkenschlager M, Fisher AG: CD45 isoform switching precedes the activation-driven death of human thymocytes by apoptosis. Intl Immunol 3:1–7, 1991
Pilarski LM, Gillitzer R, Zola H, Shortman K, Scollary R: Definition of the thymic generative lineage by selective expression of high molecular weight isoforms of CD45 (T200). Eur J Immunol 19:589–597, 1989
Paoli PD, Battistin S, Santini GF: Age-related changes in human lymphocyte subsets: Progressive reduction of the CD4 CD45R (suppressor inducer) population. Clin Immunol Immunopathol 48:290–296, 1988
Morimoto C, Letvin NL, Distaso JA, Aldrich WR, Schlossman SF: The isolation and characterization of the human suppressor inducer T cell subset. J Immunol 134:1508–1513, 1985
Bos JD, Hagenaars C, Das PK, Krieg SR, Voorn WJ, Kapsenberg ML: Predominance of “memory” T cells (CD4+, CD29+) over “naive” T cells (CD4+, CD45R+) in both normal and diseased skin. Arch Dermatol 281:24–32, 1989
Harvey J, Jones DB, Wright DH: Leucocyte common antigen expression on T cells in normal and inflamed human gut. Immunology 68:13–17, 1989
Merkenschlager M, Terry W, Edwards R, Beverley PCL: Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation. Eur J Immunol 18:1653–1661, 1988
Winterrowd GE, Sanders ME: Human memory and naive T lymphocytes have differential response to interleukin-1, interleukin-2, and interleukin-4. Clin Res 37:422A, 1989
Wasik MA, Morimoto C: Differential effects of cytokines on proliferative response of human CD4+ T lymphocytes subsets stimulated via T cell receptor complex. J Immunol 144:3334–3340, 1990
Byrne JA, Butler JL, Cooper MD: Differential activation requirements for virgin and memory T cells. J Immunol 141:3249–3257, 1988
Sanders ME, Makgoba MW, June CH, Young HA, Shaw S: Enhanced responsiveness of human memory T cells to CD2 and CD3 receptor-mediated activation. Eur J Immunol 19:803–808, 1989
Matsuyama T, Anderson P, Daley JF, Schlossman S, Morimoto C: CD4+CD45RA cells are preferentially activated through the CD2 pathway. Eur J Immunol 18:1473–1476, 1988
Anderson P, Morimoto C, Breitmeyer JB, Schlossman SF: Regulatory interactions between members of the immunoglobulin superfamily. Immunol Today 9:199–203, 1988
de Jong R, Brouwer M, Miedema F, van Lier RAW: Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation. J Immunol 146:2088–2094, 1991
Byrne JA, Butler JL, Reinherz EL, Cooper MD: Virgin and memory T cells have different requirements for activation via the CD2 molecule. Int Immunol 1:29–36, 1989
Tedder TF, Cooper MD, Clement LT: Human lymphocyte differentiation antigens HB-10 and HB-11. II. Differential production of B cell growth and differentiation factors by distinct helper T cell subpopulations. J Immunol 134:2989–2994, 1985
Sleasman JW, Morimoto C, Schlossman S, Tedder TF: The role of functionally distinct helper T lymphocyte subpopulations in the induction of human B cell differentiation. Eur J Immunol 20:1357–1366, 1990
Yamashita N, Bullington R, Clement LT: Equivalent helper functions of human “naive” and “memory” CD4+ T cells for the generation of alloreactive cytotoxic T lymphocytes. J Clin Immunol 10:237–246, 1990
Kalish RS, Morimoto C, Schlossman SF. Generation of CD8 (T8) cytotoxic cells has a preferential requirement for CD4+2H4− inducer cells. Cell Immunol 111:379–385, 1988
Takeuchi T, Rudd CE, Schlossman SF, Morimoto C: Induction of suppression following autologous mixed lymphocyte reaction: Role of a novel 2H4 antigen. Eur J Immunol 17:97–104, 1987
Takeuchi T, Rudd CE, Tanaka S, Rothstein DM, Schlossman SF, Morimoto C: Functional characterization of the CD45R(2H4) molecule on CD8(T8) cells in the AMLR system. Eur J Immunol 19:747–752, 1989
Damle NK, Childs AL, Doyle LV: Immunoregulatory T lymphocytes in man: Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+CD45R-p80+ subpopulation. J Immunol 139:1501–1508, 1987
Hirohata S, Lipsky PE: T cell regulation of human B cell proliferation and differentiation. Regulatory influences of CD45R+ and CD45R− T4 cell subsets. J Immunol 142:2597–2604, 1989
Moore K, Nesbitt AM: Identification and isolation of OKT4+ suppressor cells with the monoclonal antibody WR16. Immunology 58:659–667, 1986
Jacoby DR, Oldstone MBA: Delineation of suppressor and helper activity within the OKT4-defined T lymphocyte subset in human newborns. J Immunol 131:1765–1770, 1983
Clement LT, Vink PE, Bradley GB: Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate. J Immunol 145:102–108, 1990
Yamashita N, Clement LT: Phenotypic characterization of the post-thymic differentiation of human alloantigen-specific CD8+ cytotoxic T lymphocytes. J Immunol 143:1518–1523, 1989
Akbar AN, Salmon M, Janossy G: The synergy between naive and memory T cells during activation. Immunol Today 12:184–188, 1991
Sohen S, Rothstein DM, Tallman T, Gaudette D, Schlossman SF, Morimoto C: The functional heterogeneity of CD8+ cells defined by anti-CD45RA (2H4) and anti-CD29 (4B4) antibodies. Cell Immunol 128:314–328, 1990
Street NE, Mosmann TR: Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 5:171–177, 1991
Lewis DB, Prickett KS, Larsen A, Grabstein K, Weaver M, Wilson CB: Restricted production of interleukin 4 by activated human T cells. Proc Natl Acad Sci USA 85:9743–9747, 1988
Dohlsten M, Hedlund G, Sjogren H-O, Carlsson R: Two subsets of human CD4+ T helper cells differing in kinetics and capacities to produce interleukin 2 and interferon-τ can be defined by the Leu-18 and UCHL1 monoclonal antibodies. Eur J Immunol 18:1173–1178, 1988
Sanders ME, Makgoba MW, Sharrow SO, Stephany D, Springer TA, Young HA, Shaw S: Human memory lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-τ production. J Immunol 140:1401–1408, 1988
Salmon M, Kitas GD, Bacon PA: Production of lymphokine mRNA by CD45R+ and CD45R− helper T cells from human peripheral blood and by human CD4+ T cell clones. J Immunol 143:907–912, 1989
Morimoto C, Letvin NL, Boyd AW, Hagan M, Brown HM, Kornacki MA, Schlossman SF: The isolation and characterization of the human helper inducer T subset. J Immunol 134:3762–3771, 1985
Mackay CR: T-cell memory: The connection between function, phenotype, and migration pathways. Immunol Today 12:189–193, 1991
Camerini D, James SP, Stamenkovic I, Seed B: Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptor. Nature 342:78–82, 1989
Sanders ME, Makgoba MW, Shaw S: Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 9:195–199, 1988
Serra HM, Krowka JF, Ledbetter JA, Pilarski LM: Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event. J Immunol 140:1441–1445, 1988
Akbar AN, Terry L, Timms A, Beverley PCL, Janossy G: Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 140:2171–2176, 1988
Clement LT, Yamashita N, Martin AM: The functionally distinct subpopulations of human helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation. J Immunol 141:1464–1470, 1988
Powrie F, Mason D: The MRC OX-22- CD4+ T cells that help B cells in secondary immune responses derive from naive precursors with the MRC OX-22+ CD4+ phenotype. J Exp Med 169:653–662, 1989
Deans JP, Boyd AW, Pilarski LM: Transition from high to low molecular weight isoforms of CD45 (T200) involve a rapid activation of alternate mRNA splicing and slow turnover of surface CD45R. J Immunol 143:1233–1238, 1989
Reimhold U, Pawelec G, Fratila A, Leippold S, Bauer R, Kreyssel HW: Phenotypic and functional characterization of tumor infiltrating lymphocytes in mycosis fungoides: Continuous growth of CD4+CD45R+ T cell clones with suppressor-inducer activity. J Invest Dermatol 94:304–3089, 1990
Rothstein DM, Sohen S, Daley JF, Schlossman SF, Morimoto C: CD4+CD45RA+ and CD4+CD45R− T cell subsets in man maintain distinct function and CD45RA expression persists on a subpopulation of CD45RA+ cells after activation with con A. Cell Immunol 129:449–467, 1990
Brod SA, Rudd CE, Purvee M, Hafler DA: Lymphokine regulation of CD45R expression on human T cell clones. J Exp Med 170:2147–2151, 1989
Rothstein DM, Yamada A, Schlossman SF, Morimoto C: Cyclic regulation of CD45 isoform expression in a long-term human CD4+CD45RA+ T cell line. J Immunol 146:1175–1182, 1991
Bell EB, Sparshott SM: Interconversion of CD45R subsets of CD4 T cells in vivo. Nature. 348:163–167, 1990
Rose LM, Ginsberg AH, Rothstein DL, Ledbetter JA, Clark EA: Selective loss of a subset of T helper cells in active multiple sclerosis. Proc Natl Acad Sci USA 82:7389–7394, 1985
Morimoto C, Hafler DA, Weiner DL, Letvin NL, Hagan M, Daley J, Schlossman SF: Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis: Analysis with anti-2H4 monoclonal antibody. N Engl J Med 16:67–71, 1987
Sobel RA, Hafler DA, Castro EE, Morimoto C, Weiner HL: The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions. J Immunol 140:2210–2214, 1988
Morimoto C, Steinberg AD, Letvin NL, Hagen M, Takeuchi T, Daley J, Levine H, Schlossman SF: A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 79:762–770, 1987
Emery P, Gentry KC, Mackay IR, Muirden KD, Rowley M: Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arth Rheum 30:849–856, 1987
Pitzalis C, Kingsley G, Murphy J, Panayi G: Abnormal distribution of the helper-inducer and suppressor-inducer T lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol 45:252–258, 1987
Koch AE, Robinson PG, Radosevich JA, Pope RM: Distribution of CD45RA and CD45RO T lymphocyte subset in rheumatoid arthritis synovial tissue. J Clin Immunol 10:192–196, 1990
Rose NL, Ledbetter JA, Ginsberg AH, Clark EA, Rothstein TL: Suppressor-inducer cells in multiple sclerosis. N Engl J Med 317:118–123, 1987
Pitzalis C, Kingsley G, Haskard D, Panayi G: The preferential accumulation of helper-inducer T lymphocytes in inflamatory lesions; Evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol 18:1398–1404, 1988
LeBranchu Y, Thibault G, Degenne D, Bardos P: Deficiency of CD4+CD45R+ T lymphocytes in common variable immunodeficiency. N Engl J Med 323:276–277, 1990
Tedder TF, Crain MJ, Kubagawa H, Clement LT, Cooper MD: Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases. J Immunol 135:1786–1791, 1985
Clement LT, Giorgi JV, Plaeger-Marshall S, Haas A, Stiehm ER, Martin AM: Abnormal differentiation of immunoregulatory T lymphocyte subpopulations in the major histocompatibility complex (MHC) class II antigen deficiency syndrome. J Clin Immunol 8:503–512, 1988
Clement LT, Plaeger-Marshall S, Haas A, Saxon A, Martin AM: Bare lymphocyte syndrome: Consequences of absent class II major histocompatibility antigen expression for B lymphocyte differentiation and function. J Clin Invest 81:669–675, 1988
Giorgi JV, Detels R: Subset alteration in HIV-infected homosexual men—NIAID Multicenter AIDS Cohort study. Clin Immunol Immunopathol 52:10–18, 1989
Schnittman SM, Lane HC, Greenhouse J: Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 87:6058–6062, 1990
Schwinzer R, Wonigeit, K: Genetically determined lack of CD45R− T cells in healthy individuals. Evidence for a regulatory polymorphisms of CD45R antigen expression. J Exp Med 171:1803–1808, 1990
Clement LT, Isacescu I, Champlin R, Giorgi JV, Bradley G: Differentiation of CD4+ T cell subpopulations after allogeneic bone marrow transplantation. Clin Res 38:432A, 1990
Hayward AR, Schiff S, Buckley RH: T cell reconstitution of SCID recipients grafted with T-depleted bone marrow.In Progress in Immune Deficiency III: Royal Society of Medicine Services International Congress and Symposium Series 173, JM Chapel, RJ Levinsky, ADB Webster (eds). London, Royal Society of Medicine Service, 1991, pp 174–175
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clement, L.T. Isoforms of the CD45 common leukocyte antigen family: Markers for human T-cell differentiation. J Clin Immunol 12, 1–10 (1992). https://doi.org/10.1007/BF00918266
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918266